BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19056798)

  • 1. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
    Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.
    Correia C; Mawe S; Lofgren S; Marangoni RG; Lee J; Saber R; Aren K; Cheng M; Teaw S; Hoffmann A; Goldberg I; Cowper SE; Khatri P; Hinchcliff M; Mahoney JM
    Arthritis Res Ther; 2020 Mar; 22(1):48. PubMed ID: 32171325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound.
    Karalilova RV; Batalov ZA; Sapundzhieva TL; Matucci-Cerinic M; Batalov AZ
    Rheumatol Int; 2021 Oct; 41(10):1743-1753. PubMed ID: 34313812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis.
    Ziemek J; Man A; Hinchcliff M; Varga J; Simms RW; Lafyatis R
    Rheumatology (Oxford); 2016 May; 55(5):911-7. PubMed ID: 26880832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of cardiac magnetic resonance imaging in subclinical systemic sclerosis primary heart involvement].
    Zhao Z; Zhao YN; Jin JY; Yang JS; Zhu J; Li T
    Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):176-182. PubMed ID: 38326044
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenotypes of patients with systemic sclerosis in the Chinese Han population: a cluster analysis.
    Zhao Y; Xu W; Gao W; Li X; Liu B; Yan S; Ma Z; Yang Q
    Clin Rheumatol; 2024 May; 43(5):1635-1646. PubMed ID: 38485877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity and impact of digestive impairment perceived by patients with systemic sclerosis: a cross-sectional study.
    Cano-García L; Redondo-Rodríguez R; Mena-Vázquez N; Manrique-Arija S; García-Studer A; Ortiz-Marquez F; Borregón-Garrido P; Fernández-Nebro A
    BMJ Open; 2024 Apr; 14(4):e083419. PubMed ID: 38684244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of myotonometer in the assessment of skin involvement in systemic sclerosis.
    Öztürk Ö; Şahin D; Acar AÖ; Saldiran TÇ; Uzun NN; Şen N; Tezcan ME
    Clin Rheumatol; 2024 Feb; 43(2):695-705. PubMed ID: 38114818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of rituximab in the treatment of systemic sclerosis: A literature review.
    Yoshifuji H; Yomono K; Yamano Y; Kondoh Y; Yasuoka H
    Mod Rheumatol; 2023 Nov; 33(6):1068-1077. PubMed ID: 37053127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between hand disease severity and fatigue in individuals with systemic sclerosis: a scoping review.
    Krause D; Poole JL; Khanna D; Murphy SL
    Disabil Rehabil; 2022 Oct; 44(20):5827-5833. PubMed ID: 34388047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.
    Herrick AL; Peytrignet S; Lunt M; Pan X; Hesselstrand R; Mouthon L; Silman AJ; Dinsdale G; Brown E; Czirják L; Distler JHW; Distler O; Fligelstone K; Gregory WJ; Ochiel R; Vonk MC; Ancuţa C; Ong VH; Farge D; Hudson M; Matucci-Cerinic M; Balbir-Gurman A; Midtvedt Ø; Jobanputra P; Jordan AC; Stevens W; Moinzadeh P; Hall FC; Agard C; Anderson ME; Diot E; Madhok R; Akil M; Buch MH; Chung L; Damjanov NS; Gunawardena H; Lanyon P; Ahmad Y; Chakravarty K; Jacobsen S; MacGregor AJ; McHugh N; Müller-Ladner U; Riemekasten G; Becker M; Roddy J; Carreira PE; Fauchais AL; Hachulla E; Hamilton J; İnanç M; McLaren JS; van Laar JM; Pathare S; Proudman SM; Rudin A; Sahhar J; Coppere B; Serratrice C; Sheeran T; Veale DJ; Grange C; Trad GS; Denton CP
    Ann Rheum Dis; 2018 Apr; 77(4):563-570. PubMed ID: 29306872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups.
    Clark KEN; Xu S; Attah M; Ong VH; Buckley CD; Denton CP
    Ann Rheum Dis; 2023 Dec; 82(12):1568-1579. PubMed ID: 37580109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.
    Kwakkenbos L; Thombs BD; Khanna D; Carrier ME; Baron M; Furst DE; Gottesman K; van den Hoogen F; Malcarne VL; Mayes MD; Mouthon L; Nielson WR; Poiraudeau S; Riggs R; Sauvé M; Wigley F; Hudson M; Bartlett SJ;
    Rheumatology (Oxford); 2017 Aug; 56(8):1302-1311. PubMed ID: 28431140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins in systemic sclerosis management. A large multicenter experience.
    Tandaipan J; Guillén-Del-Castillo A; Simeón-Aznar CP; Carreira PE; De la Puente C; Narváez J; Lluch J; Rubio-Rivas M; Alegre-Sancho JJ; Bonilla G; Moriano C; Casafont-Sole I; García-Vicuña R; Ortiz-Santamaría V; Riera E; Atienza-Mateo B; Blanco R; Galisteo C; Gonzalez-Martin JJ; Pego-Reigosa JM; Pros A; Heredia S; Castellví I
    Autoimmun Rev; 2023 Nov; 22(11):103441. PubMed ID: 37708984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the Primary Cilia Gene SPAG17 and SOX9 Locus Noncoding RNAs Identified by RNA-Sequencing Analysis in Patients With Systemic Sclerosis.
    Roberson EDO; Carns M; Cao L; Aren K; Goldberg IA; Morales-Heil DJ; Korman BD; Atkinson JP; Varga J
    Arthritis Rheumatol; 2023 Jan; 75(1):108-119. PubMed ID: 35762854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis.
    Kayaalp M; Erden A; Apaydin H; Güven SC; Armağan B; Cağlayan Kayaalp M; Andac Uzdogan E; Ala Enli Ş; Omma A; Kucuksahin O
    Lab Med; 2023 Nov; 54(6):646-651. PubMed ID: 37100766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of kidneys in patients with systemic sclerosis by multi-parametric magnetic resonance quantitative imaging.
    Tong X; He H; Ning Z; Shen R; Du C; Zeng X; Wang Q; He ZX; Xu D; Zhao X
    Magn Reson Imaging; 2024 Jun; 109():203-210. PubMed ID: 38513788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for objective assessment of skin involvement in systemic sclerosis.
    Desai R; Chawla H; Larin K; Assassi S
    Curr Opin Rheumatol; 2023 Nov; 35(6):301-308. PubMed ID: 37605869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom experience of limited cutaneous systemic sclerosis from the Patients' perspective: A qualitative study
    Lescoat A; Murphy SL; Chen YT; Vann N; Galdo FD; Cella D; Buch MH; Khanna D
    Semin Arthritis Rheum; 2022 Feb; 52():151926. PubMed ID: 34785028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis.
    Ruaro B; Santiago T; Hughes M; Lepri G; Poillucci G; Baratella E; Salton F; Confalonieri M
    Open Access Rheumatol; 2021; 13():79-91. PubMed ID: 33953621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.